UNITED STATES SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2002
Commission file number: 0-27406
CONNETICS CORPORATION
| Delaware (State or other jurisdiction of incorporation or organization) |
94-3173928 (IRS Employer Identification Number) |
3290 West Bayshore Road
Palo Alto, California 94303
(Address of principal executive offices)
Registrants telephone number, including area code: (650) 843-2800
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days. Yes [X] No [ ]
As of November 8, 2002, 31,077,201 shares of the Registrants common stock were outstanding, at $0.001 par value.
CONNETICS CORPORATION
TABLE OF CONTENTS
| Page | |||||
| PART I FINANCIAL INFORMATION | |||||
| Item 1. | Condensed Consolidated Financial Statements | 1 | |||
| Condensed Consolidated Balance Sheets at September 30, 2002 and December 31, 2001 | 1 | ||||
Condensed Consolidated Statements of Operations for the three months and the nine
months ended September 30, 2002 and 2001 |
2 | ||||
Condensed Consolidated Statements of Cash Flows for the nine months ended September
30, 2002 and 2001 |
3 | ||||
Notes to Condensed Consolidated Financial Statements |
4 | ||||
| Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations | 11 | |||
| Item 3. | Quantitative and Qualitative Disclosures About Market Risks | 17 | |||
| Item 4. | Controls and Procedures | 17 | |||
| PART II OTHER INFORMATION | |||||
| Item 6. | Exhibits and Reports on Form 8-K | 17 | |||
(a) Exhibits |
17 | ||||
(b) Reports on Form 8-K |
17 | ||||
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CONNETICS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
| September 30, | December 31, | |||||||||
| 2002 | 2001 | |||||||||
| ASSETS | ||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ | 4,901 | $ | 3,603 | ||||||
Short-term investments |
24,130 | 42,734 | ||||||||
Restricted cash |
410 | 1,539 | ||||||||
Accounts receivable, net |
8,533 | 5,392 | ||||||||
Other current assets |
2,352 | 1,204 | ||||||||
Total current assets |
40,326 | 54,472 | ||||||||
Property and equipment, net |
5,566 | 3,167 | ||||||||
Restricted cash |
300 | 600 | ||||||||
Deposits and other assets |
668 | 332 | ||||||||
Goodwill, net |
6,271 | 6,132 | ||||||||
Other intangible assets, net |
6,876 | 7,624 | ||||||||
Total assets |
$ | 60,007 | $ | 72,327 | ||||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
Current liabilities: |
||||||||||
Accounts payable |
$ | 3,935 | $ | 3,636 | ||||||
Accrued payroll and related expenses |
2,450 | 2,599 | ||||||||
Accrued process development expenses |
971 | 1,209 | ||||||||
Other accrued current liabilities |
1,635 | 1,507 | ||||||||
Notes payable |
221 | | ||||||||
Other current liabilities |
720 | 663 | ||||||||
Current portion of deferred revenue |
457 | 832 | ||||||||
Total current liabilities |
10,389 | 10,446 | ||||||||
Deferred revenue, net of current portion |
428 | 527 | ||||||||
Stockholders equity: |
||||||||||
Preferred stock |
| | ||||||||
Common stock and additional paid-in capital |
168,297 | 164,300 | ||||||||
Deferred compensation |
(53 | ) | (69 | ) | ||||||
Accumulated deficit |
(120,477 | ) | (109,498 | ) | ||||||
Accumulated other comprehensive income |
1,423 | 6,621 | ||||||||
Total stockholders equity |
49,190 | 61,354 | ||||||||
Total liabilities and stockholders equity |
$ | 60,007 | $ | 72,327 | ||||||
See accompanying notes to condensed consolidated financial statements.
1
CONNETICS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended | Nine Months Ended | |||||||||||||||||
| September 30, | September 30, | |||||||||||||||||
| 2002 | 2001 | 2002 | 2001 | |||||||||||||||
Revenues: |
||||||||||||||||||
Product |
$ | 12,449 | $ | 7,650 | $ | 34,012 | $ | 21,882 | ||||||||||
Royalty |
741 | 425 | 2,156 | 548 | ||||||||||||||
License, contract and other |
451 | 123 | 1,630 | 1,789 | ||||||||||||||
Total revenues |
13,641 | 8,198 | 37,798 | 24,219 | ||||||||||||||
Operating costs and expenses: |
||||||||||||||||||
Cost of product revenues |
1,116 | 700 | 2,765 | 2,408 | ||||||||||||||
Research and development |
7,014 | 4,460 | 17,667 | 14,433 | ||||||||||||||
Selling, general and administrative |
8,497 | 8,761 | 28,823 | 26,071 | ||||||||||||||
Acquired in-process research and development |
| | 2,000 | 1,080 | ||||||||||||||
Charge for Relaxin and related liabilities |
| | 312 | 5,976 | ||||||||||||||
Total operating costs and expenses |
16,627 | 13,921 | 51,567 | 49,968 | ||||||||||||||
Loss from operations |
(2,986 | ) | (5,723 | ) | (13,769 | ) | (25,749 | ) | ||||||||||
Interest and other income |
416 | 491 | 1,213 | 2,182 | ||||||||||||||
Gain on sale of investments |
516 | | 2,086 | 122 | ||||||||||||||
Gain (loss) on foreign exchange forward contract |
| | | (554 | ) | |||||||||||||
Gain on sale of Ridaura product line |
| | | 8,055 | ||||||||||||||
Interest and other expense |
(308 | ) | (21 | ) | (444 | ) | (27 | ) | ||||||||||
Loss before income taxes |
(2,362 | ) | (5,253 | ) | (10,914 | ) | (15,971 | ) | ||||||||||
Income tax expense |
(128 | ) | (165 | ) | (65 | ) | (469 | ) | ||||||||||
Net loss |
$ | (2,490 | ) | $ | (5,418 | ) | $ | (10,979 | ) | $ | (16,440 | ) | ||||||
Basic and diluted loss per share |
$ | (0.08 | ) | $ | (0.18 | ) | $ | (0.36 | ) | $ | (0.55 | ) | ||||||
Shares used to calculate loss per share |
30,866 | 29,920 | 30,656 | 29,801 | ||||||||||||||
See accompanying notes to condensed consolidated financial statements.
2
CONNETICS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||||||||||
| September 30, | ||||||||||
| 2002 | 2001 | |||||||||
Cash flows from operating activities: |
||||||||||
Net loss |
$ | (10,979 | ) | $ | (16,440 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||
Depreciation and amortization |
1,541 | 1,339 | ||||||||
Gain on sale of investment |
(2,086 | ) | (122 | ) | ||||||
Gain on sale of Ridaura product line |
| (8,055 | ) | |||||||
Stock compensation expense |
170 | 1,568 | ||||||||
Acquired in-process research and development |
| 1,080 | ||||||||
Loss on foreign exchange forward contract |
| 555 | ||||||||
Changes in assets and liabilities, excluding effects of acquisition |
||||||||||
Accounts receivable |
(3,141 | ) | (8 | ) | ||||||
Other assets |
(941 | ) | (779 | ) | ||||||
Accounts payable |
298 | (1,348 | ) | |||||||
Accrued and other current liabilities |
(202 | ) | 1,843 | |||||||
Deferred revenue |
(474 | ) | 101 | |||||||
Net cash used in operating activities |
(15,814 | ) | (20,266 | ) | ||||||
Cash flows from investing activities: |
||||||||||
Purchases of short-term investments |
(26,151 | ) | (40,439 | ) | ||||||
Sales and maturities of short-term investments |
41,595 | 26,289 | ||||||||
Purchases of property and equipment |
(3,331 | ) | (762 | ) | ||||||
Proceeds from sale of Ridaura product line |
| 8,979 | ||||||||
Acquisition of a business, net of cash acquired |
| (16,611 | ) | |||||||
Net cash provided by (used in) investing activities |
12,113 | (22,544 | ) | |||||||
Cash flows from financing activities: |
||||||||||
Restricted cash |
1,429 | (1,859 | ) | |||||||
Payment of notes payable |
(322 | ) | (750 | ) | ||||||
Payments on obligations under capital leases |
| (37 | ) | |||||||
Proceeds from issuance of common stock, net of issuance costs |
3,844 | 1,020 | ||||||||
Net cash provided by (used in) financing activities |
4,951 | (1,626 | ) | |||||||
Effect of foreign currency exchange rates on cash and cash equivalents |
48 | (3 | ) | |||||||
Net change in cash and cash equivalents |
1,298 | (44,439 | ) | |||||||
Cash and cash equivalents at beginning of period |
3,603 | 58,314 | ||||||||
Cash and cash equivalents at end of period |
$ | 4,901 | $ | 13,875 | ||||||
See accompanying notes to condensed consolidated financial statements.
3
CONNETICS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2002
(Unaudited)
1. Basis of Presentation and Policies
We have prepared the accompanying unaudited condensed consolidated financial statements of Connetics Corporation (Connetics) in accordance with generally accepted accounting principles for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Operating results for the nine months ended September 30, 2002 are not necessarily indicative of the results that may be expected for the year ended December 31, 2002. Certain prior year balances have been reclassified for comparative purposes.
These interim results are not necessarily indicative of the results that should be expected for the full year. For a better understanding of Connetics and its financial statements, we recommend reading these unaudited, condensed, consolidated financial statements and notes in conjunction with audited financial statements and notes to those financial statements for the year ended December 31, 2001, which are included in our Annual Report on Form 10-K/A as filed with the Securities and Exchange Commission.
Principles of Consolidation
Effective April 20, 2001, we acquired Soltec Research Pty Ltd., or Soltec. In October 2002, we changed Soltecs name to Connetics Australia Pty Ltd. The accompanying unaudited condensed consolidated financial statements include the accounts of Connetics and its wholly-owned subsidiary, Connetics Australia, since April 20, 2001, the day following the acquisition. All significant intercompany accounts and transactions are eliminated in consolidation.
Use of Estimates
Management makes estimates and assumptions when preparing financial statements in conformity with accounting principles generally accepted in the United States. These estimates and assumptions affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Revenue Recognition
Product Sales. We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, when title has passed, generally upon shipment, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured. We recognize product revenue net of allowances for estimated returns, rebates, and chargebacks. We are obligated to accept from customers the return of pharmaceuticals that have reached their expiration date. To date we have not experienced significant returns of expired product. Product shipping and handling costs are included in cost of product revenues.
Royalty Revenue. Royalties from licensees are based on third-party sales. We recognize royalties in the quarter in which the royalty payment is either received from the licensee or may be reasonably estimated, which is typically one quarter following the related sale by the licensee.
Royalty expenses directly related to product sales are classified in cost of product revenues. Royalty expenses related to agreements with Connetics Australia are eliminated in consolidation.
Contract Revenue. We record contract revenue for research and development, or R&D, as it is earned based on the performance requirements of the contract. We recognize non-refundable contract fees for which no further performance obligation exists, and for which Connetics has no continuing involvement, on the earlier of when the payments are received or when collection is assured.
4
CONNETICS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
September 30, 2002
(Unaudited)
We recognize revenue from non-refundable upfront license fees ratably over the period in which we have continuing development obligations when, at the time the agreement is executed, there remains significant risk due to the incomplete stage of the products development. Revenue associated with substantial at risk performance milestones, as defined in the respective agreements, is recognized based upon the achievement of the milestones. We recognize revenue under R&D cost reimbursement contracts as the related costs are incurred. Advance payments that we receive in excess of the amount earned are classified as deferred revenue until they are earned.
Cash Equivalents and Short-term Investments
Cash and cash equivalents consist of cash on deposit with banks and money market instruments with original maturities of 90 days or less at the date of purchase. Investments with maturities beyond three months at the date of acquisition and that mature within one year from the balance sheet date are considered to be short-term investments. Short-term investments are classified as available for sale at the time of purchase and are carried at fair value, with unrealized gains and losses reported as a separate component of stockholders equity. The cost of securities sold is based on the specific identification method.
Cash equivalents and investments are financial instruments that potentially subject us to concentration of risk to the extent recorded on the balance sheet. We believe we have established guidelines for investment of our excess cash relative to diversification and maturities that maintain safety and liquidity. We invest our excess cash in debt instruments of the U.S. Government and its agencies and high-quality corporate issuers, and, by policy, restrict our exposure to any single corporate issuer by imposing concentration limits. To minimize the exposure due to adverse shifts in interest rates, we maintain investments at an average maturity of generally less than one year.
Foreign Currency
Connetics Australias functional currency is the Australian dollar. We translate Connetics Australias local currency balance sheet into U.S. dollars using the exchange rates in effect at the balance sheet date; for revenue and expense accounts we use a weighted average exchange rate during the period. Foreign currency translation adjustments are recorded in comprehensive income (loss). Net gains and losses resulting from foreign exchange transactions are included in the consolidated statement of operations and were immaterial for the nine months ended September 30, 2002 and the year ended December 31, 2001.
Income Taxes
We recognized income tax expense of $128,000 for the three-month period ended September 30, 2002 related to a foreign tax provision recorded by our Australian subsidiary, Connetics Australia. We recognized a net income tax expense of $65,000 for the nine month period ended September 30, 2002, that reflects the foreign tax provision recorded by Connetics Australia of $605,000 reduced by the tax benefit of $540,000 previously recorded in the first quarter of 2002. According to the provisions of the U.S. Job Creation and Worker Assistance Act of 2002 enacted on March 9, 2002, taxpayers are allowed to carry back net operating losses generated in 2001 and 2002 to offset alternative minimum tax paid in the last five years. For the tax year ending December 31, 2001, the Company incurred a net operating loss of approximately $25 million of which a portion of the net operating loss may be carried back to offset approximately $540,000 of alternative minimum tax incurred in the tax year ending December 31, 2000. We recognized income tax expense of $165,000 for the three-month period ended September 30, 2001 and $469,000 for the nine-month period ended September 30, 2001, all related to foreign tax provisions recorded by Connetics Australia.
5
CONNETICS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
September 30, 2002
(Unaudited)
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, generally three to five years. Leasehold improvements and assets acquired under capital lease arrangements are amortized over the shorter of the estimated useful lives of the assets or the lease term.
Impairment of Long Lived Assets
We periodically perform reviews to determine if the carrying value of long-term assets (goodwill, purchased intangibles, property and equipment) is impaired. The reviews look for existence of facts and circumstances, either internal or external, which indicate that the carrying value of the asset cannot be recovered. No such impairment has been indicated to date. If in the future management determines the existence of impairment indicators, we would use undiscounted cash flows to initially determine whether impairment should be recognized. If necessary, we would perform subsequent calculations to measure the amount of the impairment loss based on the excess of the carrying value over the fair value of the impaired assets. If quoted market prices for the assets are not available, the fair value would be calculated using the present value of estimated expected future cash flows or other appropriate valuation methodologies. The cash flow calculation would be based on managements best estimates using appropriate assumptions and projections at the time. Please see discussion below under recent accounting pronouncements regarding SFAS 144 implementation.
Recent Accounting Pronouncements
SFAS 142. In July 2001 the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets (SFAS 142). Under SFAS 142, effective January 1, 2002, we are no longer required to amortize goodwill and intangible assets with indefinite lives, but are required to periodically review these assets for impairment. Intangible assets determined to have definite lives will continue to be amortized over their useful lives. We adopted SFAS 142 effective January 1, 2002 and reclassified amounts to goodwill that were previously allocated to assembled workforce. When we adopted SFAS 142, we ceased amortizing goodwill previously representing an expense of approximately $700,000 per year. In conjunction with the implementation of SFAS 142 we performed an impairment test of goodwill as of January 1, 2002, which did not result in an impairment charge at transition. We continue to monitor the carrying value of goodwill through the required annual impairment tests. See also Note 4 Goodwill and Other Intangible Assets.
SFAS 144. In October 2001, the FASB issued Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (SFAS 144), which establishes a single accounting model for the impairment or disposal of long-lived assets, including discontinued operations. SFAS 144 supercedes SFAS 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of. SFAS 144 requires that long-lived assets to be disposed of by sale be measured at the lower of carrying amount or fair value less cost to sell, whether reported in continuing operations or in discontinued operations. SFAS 144 excludes from the definition of long-lived assets goodwill and other intangibles that are not amortized in accordance with SFAS 142. SFAS 144 also expands the reporting of discontinued operations to include components of an entity that have been or will be disposed of rather than limiting such discontinuance to a segment of a business. SFAS 144 is effective for years ending after December 15, 2001. We adopted SFAS 144 effective January 1, 2002, and experienced no impact on our financial position or results of operations, to date as a result of the adoption of this pronouncement.
6
CONNETICS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
September 30, 2002
(Unaudited)
SFAS 146. In July 2002, the FASB issued Statement of Financial Accounting Standards No. 146, Accounting for Costs Associated with Exit and Disposal Activities (SFAS 146). This statement revises the accounting for exit and disposal activities under Emerging Issues Task Force Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. A formal commitment to a plan to exit an activity or dispose of long-lived assets will no longer be sufficient to record a one-time charge for most exit and disposal costs. Instead, companies will record exit or disposal costs when they are incurred and can be measured at fair value, rather than when the company commits to such an activity. The provisions of SFAS 146 are effective prospectively for exit or disposal activities initiated after December 31, 2002. Upon the adoption of SFAS 146, previously issued financial statements shall not be restated. We will assess the impact of adoption of SFAS 146 based on the nature of transactions ongoing at the adoption date.
2. Net Income (Loss) Per Share
We compute basic net income (loss) per common share by dividing net income (loss) applicable to common stockholders by the weighted average of common shares outstanding during the period. We compute diluted net income per share using the weighted average of common and diluted equivalent stock options and warrants outstanding during the period. We excluded all stock options and warrants from the calculation of diluted loss per common share for the nine months ended September 30, 2002 and September 30, 2001 because these securities are anti-dilutive during these periods.
3. Comprehensive Loss
During the three and nine month periods ended September 30, 2002, total comprehensive loss amounted to $2.4 million and $16.2 million, respectively, compared to a comprehensive loss of $5.1 million and $17.5 million for the comparable periods in 2001. The components of comprehensive loss for the three and nine month periods ended September 30, 2002 and September 30, 2001 are as follows:
| Three months ended | Nine months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2002 | 2001 | 2002 | 2001 | |||||||||||||
| (In thousands) | ||||||||||||||||
Net loss |
$ | (2,490 | ) | $ | (5,418 | ) | $ | (10,979 | ) | $ | (16,440 | ) | ||||
Foreign currency translation adjustment |
(31 | ) | (2 | ) | 48 | (3 | ) | |||||||||
Change in unrealized gain (loss) on
securities, net of reclassification
adjustments for realized gain (loss) |
94 | 348 | (5,246 | ) | (1,064 | ) | ||||||||||
Comprehensive loss |
$ | (2,427 | ) | $ | (5,072 | ) | $ | (16,177 | ) | $ | (17,507 | ) | ||||
4. Goodwill and Other Intangible Assets
In April 2001, we acquired Connetics Australia (then called Soltec) and accounted for the acquisition using the purchase method of accounting. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed based on their estimated fair values on the acquisition date. We purchased all of the shares of Connetics Australias capital stock for cash of $16.9 million plus transaction costs of approximately $250,000. The purchase price was allocated to: existing technology of $6.8 million, goodwill of $6.6 million, tangible net assets assumed of $1.3 million, patents and core technology of $1.2 million, acquired in-process research and development of $1.1 million, and assembled workforce of $150,000.
7
CONNETICS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
September 30, 2002
(Unaudited)
When we adopted SFAS 142 effective January 1, 2002 we reclassified amounts to goodwill that were previously allocated to assembled workforce. At that time, we ceased amortizing goodwill previously representing an expense of approximately $700,000 per year.
We will continue to amortize other intangible assets that meet the criteria for separate recognition from goodwill over their useful lives. We completed a transitional goodwill impairment test as of January 1, 2002 in the second quarter of fiscal 2002, which did not result in an impairment charge. SFAS 142 also requires that goodwill be tested for impairment on an annual basis or more frequently if indicators of potential impairment exist. We are still in the process of selecting the date on which to perform the annual test.
Changes in the carrying amount of goodwill for the nine-month period ended September 30, 2002, is as follows (in thousands):
Balance as of December 31, 2001 |
$ | 6,132 | ||
Reclassification of net intangible asset assembled workforce into goodwill |